Health In Tech Nasdaq/NYSE Compliance Notice
Health In Tech received two deficiency notices from Nasdaq regarding its failure to maintain a majority of independent directors on its board and for its stock price falling below the $1.00 minimum bid requirement for 30 consecutive days. The company has until April 12, 2027, to regain compliance with the bid price rule and until its next annual meeting to resolve the board independence issue. Management expects to regain compliance following the election of a new independent director at the annual meeting scheduled for November 10, 2026.
- Counterparty
- The Nasdaq Stock Market LLC
- Term
- 180 days